Medical Device Network on MSN
BCI implant’s trial success prefigures ‘new era’ in eye care
In Science Corporation’s BCI retinal implant trial, 84% of patients who had lost their sight to dry AMD could read letters, numbers and words using prosthetic vision.
Science Corporation, the neural engineering and brain-computer interface (BCI) company, today announced the European commercial launch of PRIMA, the first and only treatment shown in clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results